Bryn Mawr Capital Management LLC Buys 7,239 Shares of CME Group Inc. (NASDAQ:CME)

Bryn Mawr Capital Management LLC increased its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 17.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 47,615 shares of the financial services provider's stock after purchasing an additional 7,239 shares during the period. Bryn Mawr Capital Management LLC's holdings in CME Group were worth $12,632,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Wayfinding Financial LLC purchased a new stake in CME Group during the 1st quarter worth $25,000. Cornerstone Planning Group LLC raised its stake in shares of CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after purchasing an additional 55 shares in the last quarter. New Age Alpha Advisors LLC raised its stake in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after acquiring an additional 43 shares during the period. Golden State Wealth Management LLC raised its stake in CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after acquiring an additional 98 shares during the period. Finally, Alpine Bank Wealth Management acquired a new stake in CME Group during the first quarter worth about $32,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Down 1.1%

Shares of CME Group stock traded down $3.12 during trading on Friday, reaching $274.70. 2,122,369 shares of the company traded hands, compared to its average volume of 2,178,371. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1-year low of $193.25 and a 1-year high of $290.79. The company has a 50 day moving average price of $276.08 and a 200-day moving average price of $260.36. The firm has a market capitalization of $98.99 billion, a PE ratio of 27.64, a P/E/G ratio of 4.86 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The firm had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the prior year, the company posted $2.50 earnings per share. The business's revenue was up 10.4% on a year-over-year basis. As a group, equities research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were given a dividend of $1.25 per share. The ex-dividend date of this dividend was Monday, June 9th. This represents a $5.00 annualized dividend and a yield of 1.82%. CME Group's payout ratio is currently 50.30%.

Insider Activity at CME Group

In other CME Group news, Director Phyllis M. Lockett sold 1,060 shares of the firm's stock in a transaction on Monday, May 19th. The shares were sold at an average price of $277.88, for a total value of $294,552.80. Following the completion of the transaction, the director directly owned 3,108 shares of the company's stock, valued at $863,651.04. This trade represents a 25.43% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Larry G. Gerdes sold 2,000 shares of the firm's stock in a transaction that occurred on Thursday, April 24th. The shares were sold at an average price of $264.10, for a total transaction of $528,200.00. Following the completion of the sale, the director directly owned 38,651 shares in the company, valued at $10,207,729.10. This represents a 4.92% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 13,400 shares of company stock valued at $3,680,610 in the last 90 days. 0.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

CME has been the subject of several recent analyst reports. Citigroup upped their target price on shares of CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a research report on Thursday, July 3rd. Wall Street Zen downgraded shares of CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Morgan Stanley increased their target price on shares of CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a research report on Thursday, April 24th. JPMorgan Chase & Co. cut their target price on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research report on Thursday, April 24th. Finally, Bank of America increased their price target on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research note on Wednesday, April 2nd. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $261.80.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.